CA1302278C - Injection solutions of torasemide which are ready to use and processes for their preparation thereof - Google Patents

Injection solutions of torasemide which are ready to use and processes for their preparation thereof

Info

Publication number
CA1302278C
CA1302278C CA000540941A CA540941A CA1302278C CA 1302278 C CA1302278 C CA 1302278C CA 000540941 A CA000540941 A CA 000540941A CA 540941 A CA540941 A CA 540941A CA 1302278 C CA1302278 C CA 1302278C
Authority
CA
Canada
Prior art keywords
torasemide
organic solvent
molecular weight
solution
injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000540941A
Other languages
English (en)
French (fr)
Inventor
Fritz Demmer
Werner Gruber
Heinrich Woog
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of CA1302278C publication Critical patent/CA1302278C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Pyridine Compounds (AREA)
  • Ink Jet (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
CA000540941A 1986-07-12 1987-06-30 Injection solutions of torasemide which are ready to use and processes for their preparation thereof Expired - Lifetime CA1302278C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3623620.9 1986-07-12
DE19863623620 DE3623620A1 (de) 1986-07-12 1986-07-12 Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
CA1302278C true CA1302278C (en) 1992-06-02

Family

ID=6305087

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000540941A Expired - Lifetime CA1302278C (en) 1986-07-12 1987-06-30 Injection solutions of torasemide which are ready to use and processes for their preparation thereof

Country Status (13)

Country Link
US (1) US4861786A (OSRAM)
EP (1) EP0253226B1 (OSRAM)
JP (1) JPS6323818A (OSRAM)
KR (1) KR950010158B1 (OSRAM)
AT (1) ATE53296T1 (OSRAM)
AU (1) AU578562B2 (OSRAM)
CA (1) CA1302278C (OSRAM)
DE (2) DE3623620A1 (OSRAM)
DK (1) DK174624B1 (OSRAM)
ES (1) ES2016306B3 (OSRAM)
FI (1) FI87993C (OSRAM)
GR (1) GR3000534T3 (OSRAM)
NZ (1) NZ221026A (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486530A (en) * 1991-04-27 1996-01-23 Boehringer Mannheim Gmbh Use of torasemide for the treatment of brain oedemas
DE4126984A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, gut vertraeglichen arzneimitteln fuer infusions- oder injektionszwecke
JP3028171B2 (ja) * 1993-08-31 2000-04-04 日本ピラー工業株式会社 複合ガスケット
US6228873B1 (en) 1994-12-09 2001-05-08 The Regents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
US5585401A (en) * 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
US5763491A (en) * 1994-12-09 1998-06-09 The Regents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
HK1046636A1 (zh) 1999-08-11 2003-01-24 Teva Pharmaceutical Industries Ltd. 多晶型托拉塞米
CN1203059C (zh) 2000-03-20 2005-05-25 特瓦制药工业有限公司 新的制备托拉塞米中间体的方法
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
AU2003205278B2 (en) * 2002-01-18 2008-08-07 Psivida Us Inc. Polymeric gel system for the controlled delivery of codrugs
CN100372534C (zh) * 2006-04-20 2008-03-05 南京海辰药业有限公司 托拉塞米冻干制剂及制备方法
US20100053852A1 (en) * 2008-09-02 2010-03-04 Cheng Uei Precision Industry Co., Ltd. Display Device
CN103371967A (zh) * 2012-04-17 2013-10-30 上海禾丰制药有限公司 呋塞米注射液及其制剂工艺
SG11201508251RA (en) 2013-04-05 2015-11-27 Scpharmaceuticals Llc Pharmaceutical formulations for subcutaneous administration of furosemide
FR3077984B1 (fr) * 2018-02-16 2020-02-21 Vetoquinol Sa Composition multiusage de torasemide
JP7465881B2 (ja) 2019-01-31 2024-04-11 エスシーファーマシューティカルズ インコーポレイテッド フロセミドの濃縮液体医薬製剤及びそれを投与する方法
CN110606826B (zh) * 2019-05-23 2021-06-01 上海勋和医药科技有限公司 托拉塞米钠一水合物、其晶型及组合物
CN112168776B (zh) * 2020-10-30 2022-05-03 康普药业股份有限公司 一种低杂质高稳定的托拉塞米注射液和制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE30681C (de) * R.W. traylor in Richmond, County of Henrico State of Virginia, V. St. A Gufsform aus Glimmer
DE185374C (OSRAM) *
DK138974B (da) * 1974-02-19 1978-11-27 Ciba Geigy Ag Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
DE2950832C2 (de) * 1979-12-18 1983-03-17 Hoechst Ag, 6000 Frankfurt Spritzfertige injizierbare wäßrige Lösungen der Alkalisalze von Canrenoinsäure und Furosemid
DE3241765A1 (de) * 1982-11-11 1984-05-17 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin Stabile zubereitungen fuer injektionszwecke enthaltend hydrochlorothiazid
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
DE3529529A1 (de) * 1985-08-17 1987-02-19 Boehringer Mannheim Gmbh Verfahren zur herstellung einer stabilen modifikation von torasemid

Also Published As

Publication number Publication date
DE3623620C2 (OSRAM) 1991-02-28
DE3623620A1 (de) 1988-01-21
DK360287D0 (da) 1987-07-10
AU7535587A (en) 1988-01-14
EP0253226A1 (de) 1988-01-20
ES2016306B3 (es) 1990-11-01
FI87993B (fi) 1992-12-15
FI873059L (fi) 1988-01-13
FI873059A0 (fi) 1987-07-10
FI87993C (fi) 1993-03-25
DK360287A (da) 1988-01-13
JPS6323818A (ja) 1988-02-01
KR880001294A (ko) 1988-04-22
GR3000534T3 (en) 1991-07-31
JPH055810B2 (OSRAM) 1993-01-25
DE3763010D1 (de) 1990-07-12
AU578562B2 (en) 1988-10-27
US4861786A (en) 1989-08-29
KR950010158B1 (ko) 1995-09-11
EP0253226B1 (de) 1990-06-06
ATE53296T1 (de) 1990-06-15
NZ221026A (en) 1989-09-27
DK174624B1 (da) 2003-07-28

Similar Documents

Publication Publication Date Title
CA1302278C (en) Injection solutions of torasemide which are ready to use and processes for their preparation thereof
KR920003332B1 (ko) 에토포시드(Etoposide)제제의 제조방법
JPS6191116A (ja) 安定化された注射用ピロキシカム液剤
EP0189941B1 (en) Antibiotic compositions
CA1263398A (en) 2-amino-3-ethoxycarbonylamino-6-(p-fluoro- benzylamino)-pyridine gluconate, process for its production and pharmaceutical preparations containing it
FI70793C (fi) Foerfarande foer framstaellning av en stabil 4'-(9-akridinylamino)metansulfon -m-anisidin(m-amsa)-komposition
JP3720262B2 (ja) 安定化したカルベジロール注射溶液
US4696814A (en) Parenteral phenytoin compositions
AU688305B2 (en) Process to prepare pharmaceutical compositions containing vecuronium bromide
EP0038013B1 (en) Injectable oxytetracycline compositions
EP0029668B1 (en) Pharmaceutical injectable composition and two-pack container for said composition
EP0180303B1 (en) Parenteral composition
FI72045C (fi) Foerfarande foer framstaellning av en stabil loesning av dihydroergotaminmetansulfonat och natriumheparinat.
US5034397A (en) Stable, water soluble salt compositions of M-AMSA in 1-methyl-2-pyrrolidinone
US4425348A (en) Antitumor compositions
JPH0366617A (ja) 静脈内投与用フエニトインナトリウム製剤
EP1508332A1 (en) Medicinal composition
US4386083A (en) Injectable oxytetracycline compositions
US4399127A (en) Injectable oxytetracycline compositions
IE44733B1 (en) Theophylline compositions
US4322424A (en) Crystalline glucoconate salt of m-AMSA and compositions containing same
JP3242924B2 (ja) 調製済みのアゾセミド（ａｚｏｓｅｍｉｄｅ）注射液
FI82378B (fi) Foerfarande foer framstaellning av injiserbara oxitetracyklinloesningar.
WO1992014479A1 (fr) Composition pour administration par voie rectale de peptides difficiles a absorber
US4663458A (en) Water soluble salt composition of m-AMSA

Legal Events

Date Code Title Description
MKEX Expiry